Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers
Safiye Akkın, Gamze Varan, Erem Bilensoy
Molecules (2021) Vol. 26, Iss. 11, pp. 3382-3382
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Development of Platinum Complexes for Tumor Chemoimmunotherapy
S. Jin, Yan Guo, Xiaoyong Wang
Chemistry - A European Journal (2024) Vol. 30, Iss. 10
Closed Access | Times Cited: 16
EGFR-Targeted Photodynamic Therapy
Luca Ulfo, Paolo Emidio Costantini, Matteo Di Giosia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 241-241
Open Access | Times Cited: 64
Drug Delivery Systems for Localized Cancer Combination Therapy
Ryan N. Woodring, Elizabeth G. Graham-Gurysh, Eric M. Bachelder, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 3, pp. 934-950
Open Access | Times Cited: 32
Hotspots evolution and frontiers of immunotherapy for the treatment of acute myeloid leukemia: A bibliometric analysis
Nana Zhe, Qiang Li, Nanqu Huang, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 1
UiO-based platforms in biomedicine: Advanced nanovehicles for effective treatment
Ren Zhang, Abdulnasser Mahmoud Karami, Qianying Huang, et al.
Materials Today Chemistry (2025) Vol. 45, pp. 102645-102645
Closed Access | Times Cited: 1
Natural products and their derivatives as immune check point inhibitors: Targeting cytokine/chemokine signalling in cancer
Meenakshi Gupta, Kumari Chandan, Maryam Sarwat
Seminars in Cancer Biology (2022) Vol. 86, pp. 214-232
Closed Access | Times Cited: 36
Engineering nanosystems to overcome barriers to cancer diagnosis and treatment
Suhaila O. Alhaj‐Suliman, Emad I. Wafa, Aliasger K. Salem
Advanced Drug Delivery Reviews (2022) Vol. 189, pp. 114482-114482
Open Access | Times Cited: 35
Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 844-875
Open Access | Times Cited: 34
SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer
Yunlong Lu, Xinyu Sheng, Haiping Hao, et al.
Pharmacological Research (2023) Vol. 190, pp. 106731-106731
Open Access | Times Cited: 20
Nanoparticle drug delivery systems in hepatocellular carcinoma: A focus on targeting strategies and therapeutic applications
Sayali Pravin Metkar, Gasper Fernandes, Prerana D. Navti, et al.
OpenNano (2023) Vol. 12, pp. 100159-100159
Open Access | Times Cited: 19
Supramolecular self-assembled peptide-engineered nanofibers: A propitious proposition for cancer therapy
Giriraj Pandey, Vivek Phatale, Pooja Khairnar, et al.
International Journal of Biological Macromolecules (2023) Vol. 256, pp. 128452-128452
Closed Access | Times Cited: 17
Doxorubicin-sanguinarine nanoparticles: formulation and evaluation of breast cancer cell apoptosis and cell cycle
Mahmoud Zaki El-Readi, Majed Abdurhman Abdulkarim, Ahmed A. H. Abdellatif, et al.
Drug Development and Industrial Pharmacy (2024), pp. 1-15
Closed Access | Times Cited: 8
Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis
Ying Liu, Sixin Li, Lu Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Targeting the innate immune system with nanoparticles for cancer immunotherapy
Kai Li, Zhicheng Zhang, Yu Mei, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 11, pp. 1709-1733
Closed Access | Times Cited: 23
Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy
Zhiyuan Li, Qing‐Hua Shen, Zong‐Wan Mao, et al.
Chemistry - An Asian Journal (2022) Vol. 17, Iss. 13
Closed Access | Times Cited: 23
Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies
Charlotte Bouquerel, Anastasiia Dubrova, Isabella Hofer, et al.
Lab on a Chip (2023) Vol. 23, Iss. 18, pp. 3906-3935
Open Access | Times Cited: 15
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study
Javier García Corbacho, Alberto Indacochea, Azucena E. González Navarro, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 6, pp. 1709-1723
Open Access | Times Cited: 14
All-Rounder Liposomes in Cancer Immunotherapy: Strategies and Design Applications of Engineered Liposomal Nanomaterials
Gahyun Lee, Yonghyun Choi, Joohye Hong, et al.
BioChip Journal (2024) Vol. 18, Iss. 2, pp. 211-232
Closed Access | Times Cited: 4
Engineered Nanoparticles for Enhanced Antitumoral Synergy Between Macrophages and T Cells in the Tumor Microenvironment
Sang-Jun Moon, Mungyo Jung, Seokhyeong Go, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 4
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study
Javier García Corbacho, Alberto Indacochea, Iván Victoria, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
Beatriz Ramos‐Solano, Dakota Rogers
annals of urologic oncology (2025)
Open Access
PEGylated Pharmaceutical Nanocarriers
Prashant Pingale, Sakshi Pravin Wani, Sahebrao Boraste, et al.
(2025), pp. 1-28
Closed Access
A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia
Yaoyao Wang, Xiancong Yang, Yalin Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Chemoimmunotherapy synergism: mechanisms and clinical applications
Rahaman Shaik, Sai Manasa Chittepu, Meghana Tarapatla, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Harnessing exosomes for targeted drug delivery systems to combat brain cancer
Abdullah E Basyoni, Amira Atta, Maha M. Salem, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top